Skip to main content
NCBI home page
Annals of Surgery logoLink to Annals of Surgery
. 1987 Aug;206(2):210–213. doi: 10.1097/00000658-198708000-00015

A comparison between 25% albumin and 6% hydroxyethyl starch solutions on lung water accumulation during and immediately after cardiopulmonary bypass.

P D Lumb
PMCID: PMC1493097  PMID: 2440391

Abstract

Six per cent hydroxyethyl starch was compared prospectively with 25% albumin as the oncotic component of cardiopulmonary pump prime solutions. Oncotic pressure of the pump prime solution was measured, and serum oncotic pressure (OP) values were recorded at designated times during the perioperative period. Changes in these values were compared with alterations in extravascular lung water (EVLW), the serum oncotic pressure-pulmonary artery occluded pressure gradient and the alveolar-arterial difference in oxygen tension [D(A-a)O2] before and immediately after bypass and in the surgical intensive care unit after operation. A significant increase in EVLW was associated with a decrease in serum OP and an increase in D(A-a)O2 immediately after bypass. However, EVLW values had returned to baseline by time of determination in the surgical intensive care unit. Cost savings may be realized by the use of hydroxyethyl starch in this setting if average wholesale price data are representative of costs throughout the country.

Full text

PDF
210

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Beattie H. W., Evans G., Garnett E. S., Regoeczi E., Webber C. E., Wong K. L. Albumin and water fluxes during cardiopulmonary bypass. J Thorac Cardiovasc Surg. 1974 Jun;67(6):926–931. [PubMed] [Google Scholar]
  2. Byrick R. J., Kay C., Noble W. H. Extravascular lung water accumulation in patients following coronary artery surgery. Can Anaesth Soc J. 1977 May;24(3):332–345. doi: 10.1007/BF03005106. [DOI] [PubMed] [Google Scholar]
  3. Chenoweth D. E., Cooper S. W., Hugli T. E., Stewart R. W., Blackstone E. H., Kirklin J. W. Complement activation during cardiopulmonary bypass: evidence for generation of C3a and C5a anaphylatoxins. N Engl J Med. 1981 Feb 26;304(9):497–503. doi: 10.1056/NEJM198102263040901. [DOI] [PubMed] [Google Scholar]
  4. Culliford A. T., Thomas S., Spencer F. C. Fulminating noncardiogenic pulmonary edema. A newly recognized hazard during cardiac operations. J Thorac Cardiovasc Surg. 1980 Dec;80(6):868–875. [PubMed] [Google Scholar]
  5. Diehl J. T., Lester J. L., 3rd, Cosgrove D. M. Clinical comparison of hetastarch and albumin in postoperative cardiac patients. Ann Thorac Surg. 1982 Dec;34(6):674–679. doi: 10.1016/s0003-4975(10)60907-1. [DOI] [PubMed] [Google Scholar]
  6. Gallagher J. D., Moore R. A., Kerns D., Jose A. B., Botros S. B., Flicker S., Naidech H., Clark D. L. Effects of colloid or crystalloid administration on pulmonary extravascular water in the postoperative period after coronary artery bypass grafting. Anesth Analg. 1985 Aug;64(8):753–758. [PubMed] [Google Scholar]
  7. Gollub S., Vanichanan C., Schaefer C., Schechter D. C. A study of safer plasma substitutes. Surg Gynecol Obstet. 1969 Jun;128(6):1235–1243. [PubMed] [Google Scholar]
  8. Kirklin J. K., Lell W. A., Kouchoukos N. T. Hydroxyethyl starch versus albumin for colloid infusion following cardiopulmonary bypass in patients undergoing myocardial revascularization. Ann Thorac Surg. 1984 Jan;37(1):40–46. doi: 10.1016/s0003-4975(10)60707-2. [DOI] [PubMed] [Google Scholar]
  9. Lazrove S., Waxman K., Shippy C., Shoemaker W. C. Hemodynamic, blood volume, and oxygen transport responses to albumin and hydroxyethyl starch infusions in critically ill postoperative patients. Crit Care Med. 1980 May;8(5):302–306. doi: 10.1097/00003246-198005000-00007. [DOI] [PubMed] [Google Scholar]
  10. Lee W. H., Jr, Cooper N., Weidner M. G., Jr, Murner E. S. Clinical evaluation of a new plasma expander hydroxyethyl starch. J Trauma. 1968 May;8(3):381–393. doi: 10.1097/00005373-196805000-00005. [DOI] [PubMed] [Google Scholar]
  11. Lewis F. R., Elings V. B., Sturm J. A. Bedside measurement of lung water. J Surg Res. 1979 Oct;27(4):250–261. doi: 10.1016/0022-4804(79)90138-0. [DOI] [PubMed] [Google Scholar]
  12. Ohqvist G., Settergren G., Lundberg S. Pulmonary oxygenation, central haemodynamics and glomerular filtration following cardiopulmonary bypass with colloid or non-colloid priming solution. Scand J Thorac Cardiovasc Surg. 1981;15(3):257–262. doi: 10.3109/14017438109100583. [DOI] [PubMed] [Google Scholar]
  13. Palanzo D. A., Parr G. V., Bull A. P., Williams D. R., O'Neill M. J., Waldhausen J. A. Hetastarch as a prime for cardiopulmonary bypass. Ann Thorac Surg. 1982 Dec;34(6):680–683. doi: 10.1016/s0003-4975(10)60908-3. [DOI] [PubMed] [Google Scholar]
  14. Puri V. K., Paidipaty B., White L. Hydroxyethyl starch for resuscitation of patients with hypovolemia and shock. Crit Care Med. 1981 Dec;9(12):833–837. doi: 10.1097/00003246-198112000-00006. [DOI] [PubMed] [Google Scholar]
  15. Sade R. M., Crawford F. A., Jr, Dearing J. P., Stroud M. Hydroxyethyl starch in priming fluid for cardiopulmonary bypass. J Thorac Cardiovasc Surg. 1982 Jul;84(1):35–38. [PubMed] [Google Scholar]
  16. Sade R. M., Stroud M. R., Crawford F. A., Jr, Kratz J. M., Dearing J. P., Bartles D. M. A prospective randomized study of hydroxyethyl starch, albumin, and lactated Ringer's solution as priming fluid for cardiopulmonary bypass. J Thorac Cardiovasc Surg. 1985 May;89(5):713–722. [PubMed] [Google Scholar]
  17. THOMPSON W. L., WALTON R. P. CIRCULATORY RESPONSES TO INTRAVENOUS INFUSIONS OF HYDROXYETHYL STARCH SOLUTIONS. J Pharmacol Exp Ther. 1964 Dec;146:359–364. [PubMed] [Google Scholar]
  18. Weil M. H., Morissette M., Michaels S., Bisera J., Boycks E., Shubin H., Jacobson E. Routine plasma colloid osmotic pressure measurements. Crit Care Med. 1974 Sep-Oct;2(5):229–234. doi: 10.1097/00003246-197409000-00001. [DOI] [PubMed] [Google Scholar]

Articles from Annals of Surgery are provided here courtesy of Lippincott, Williams, and Wilkins

RESOURCES